Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Cheol Joo Yoo"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
Sun Min Lim, Cheol Joo Yoo, Jung Woo Han, Yong Jin Cho, Soo Hee Kim, Joong Bae Ahn, Sun Young Rha, Sang Joon Shin, Hyun Cheol Chung, Woo Ick Yang, Kyoo-Ho Shin, Jae Kyung Rho, Hyo Song Kim
Cancer Res Treat. 2015;47(1):9-17.   Published online August 21, 2014
DOI: https://doi.org/10.4143/crt.2013.157
AbstractAbstract PDFPubReaderePub
Purpose
Pediatric-type sarcomas such as rhabdomyosarcoma (RMS), Ewing sarcoma (EWS), primitive neuroectodermal tumor (PNET), and desmoplastic small round-cell tumor (DSRCT) are rare in adults, with limited studies on their prognosis and optimal treatment strategies. We aimed to examine the outcome of children and adult patients with RMS, EWS, PNET, and DSRCT and relevant prognostic factors. Materials and Methods We retrospectively reviewed 220 pediatric-type sarcoma patients at a single institution between 1985 and 2011. Comparisons were made in order to examine differences in demographics, disease characteristics, and survival. Survival analyses were performed using the Kaplan-Meier method with log-rank tests and Cox proportional hazards models. Results A total of 220 consecutive patients were identified at our institute. Median age was 15.6 years (range, 0 to 81 years) and there were 108 children (49%) and 112 adult patients (51%). According to histological classification, 106 patients (48.2%) had RMS, 60 (27.3%) had EWS, 50 (22.7%) had PNET, and 4 (1.8%) had DSRCT. With a median follow-up period of 6.6 years, the estimated median overall survival (OS) of all patients was 75 months (95% confidence interval [CI], 27.2 to 122.8 months) and median event-free survival (EFS) for all patients was 11 months (95% CI, 8.8 to 13.2 months). No significant difference in OS and EFS was observed between adults and children. In multivariate analysis, distant metastasis (hazard ratio [HR], 1.617; 95% CI, 1.022 to 2.557; p=0.040) and no debulking surgery (HR, 1.443; 95% CI, 1.104 to 1.812; p=0.012) showed independent association with worse OS. Conclusion Metastatic disease and no surgical treatment are poor prognostic factors for OS among pediatric-type sarcomas for both adults and children.

Citations

Citations to this article as recorded by  
  • CAR-T Therapies in Solid Tumors: Opportunities and Challenges
    Grace Guzman, Megan R. Reed, Kevin Bielamowicz, Brian Koss, Analiz Rodriguez
    Current Oncology Reports.2023; 25(5): 479.     CrossRef
  • Clinicopathological and treatment response characteristics of updated rhabdomyosarcoma histomolecular subtypes: An Asian population‐based study
    Guo Yuan How, Chik Hong Kuick, Min Hwee Yong, Shui Yen Soh, Esther XY Hee, Meng Kang Wong, Richard Quek, Mohd Farid Harunal, Sathiyamoorthy Selvarajan, Kesavan Sittampalam, Chetan Anil Dhamne, Victor Lee, Kenneth TE Chang, Amos HP Loh
    Asia-Pacific Journal of Clinical Oncology.2023;[Epub]     CrossRef
  • Pediatric sarcoma survivorship: A call for a developmental cascades approach
    Peter M. Fantozzi, Gina Sprint, Anna Marie Medina
    Development and Psychopathology.2022; 34(4): 1221.     CrossRef
  • Clinical Perspectives for 18F-FDG PET Imaging in Pediatric Oncology: Μetabolic Tumor Volume and Radiomics
    Vassiliki Lyra, Sofia Chatziioannou, Maria Kallergi
    Metabolites.2022; 12(3): 217.     CrossRef
  • Desmoplastic Small Round Cell Tumors With EWS-WT1 Transcript Expression: Should We Consider Children and Adult Patients Differently?
    Laura Olivier-Gougenheim, Daniel Orbach, Vincent Atallah, Perrine Marec-Berard, Amandine Bertrand
    Journal of Pediatric Hematology/Oncology.2022; 44(3): e637.     CrossRef
  • Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
    Antonio Juan Ribelles, Pablo Gargallo, Pablo Berlanga, Vanessa Segura, Yania Yáñez, Bárbara Juan, Marta Salom, Margarita Llavador, Jaime Font de Mora, Victoria Castel, Adela Cañete
    Journal of Personalized Medicine.2021; 11(4): 268.     CrossRef
  • Ewing Sarcoma
    Hee Young Ju
    Clinical Pediatric Hematology-Oncology.2019; 26(1): 27.     CrossRef
  • Emerging trends in immunotherapy for pediatric sarcomas
    Kyle A. Dyson, Brian D. Stover, Adam Grippin, Hector R. Mendez-Gomez, Joanne Lagmay, Duane A. Mitchell, Elias J. Sayour
    Journal of Hematology & Oncology.2019;[Epub]     CrossRef
  • 24,182 View
  • 140 Download
  • 10 Web of Science
  • 8 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP